• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西圣保罗州参考中心报告的大流行性流感 A (H1N1) 免疫接种后不良事件自发报告。

Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of São Paulo, Brazil.

机构信息

Centro de Referência para Imunobiológicos Especiais, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Rev Soc Bras Med Trop. 2013 May-Jun;46(3):348-51. doi: 10.1590/0037-8682-1265-2013.

DOI:10.1590/0037-8682-1265-2013
PMID:23856866
Abstract

INTRODUCTION

This paper describes adverse events (AEs) temporally associated to the pandemic influenza A (H1N1) vaccine observed in a reference center in São Paulo, Brazil, during a 2010 mass vaccination campaign.

METHODS

A retrospective study involving persons who sought medical care for AEs following influenza vaccination. Data were retrieved from medical records, vaccine AE notification forms, and a computerized system for immunobiological registration.

RESULTS

Sixty-six vaccinees sought medical care for AEs after immunization. The most frequent AEs were fever, headache, myalgia, and pain at the injection site. No serious AEs were reported.

CONCLUSIONS

Few vaccinees spontaneously reported AEs to influenza A (H1N1) vaccine at this center.

摘要

简介

本文描述了在巴西圣保罗的一个参考中心,在 2010 年大规模疫苗接种运动期间,与大流行流感 A(H1N1)疫苗相关的不良事件(AE)。

方法

一项回顾性研究,涉及因接种流感疫苗后出现 AE 而寻求医疗的人员。数据来自医疗记录、疫苗 AE 通知表和免疫生物学登记的计算机系统。

结果

66 名接种者在接种疫苗后因 AE 寻求医疗。最常见的 AE 是发热、头痛、肌痛和注射部位疼痛。没有报告严重的 AE。

结论

在该中心,少数接种者自发报告了大流行流感 A(H1N1)疫苗的 AE。

相似文献

1
Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of São Paulo, Brazil.巴西圣保罗州参考中心报告的大流行性流感 A (H1N1) 免疫接种后不良事件自发报告。
Rev Soc Bras Med Trop. 2013 May-Jun;46(3):348-51. doi: 10.1590/0037-8682-1265-2013.
2
Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.肺移植受者中 2009 年 H1N1 大流行流感病毒疫苗接种:苏黎世队列中的覆盖率、安全性和临床效果。
J Heart Lung Transplant. 2011 Jun;30(6):685-90. doi: 10.1016/j.healun.2011.01.707. Epub 2011 Mar 27.
3
Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.在拉丁美洲和加勒比地区甲型H1N1流感大流行疫苗接种活动期间,据认为可归因于疫苗接种或免疫的事件。
Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.
4
Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.韩国甲型 H1N1 流感大流行疫苗接种后不良事件的主动监测。
Jpn J Infect Dis. 2011;64(4):297-303.
5
Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.巴西 2010 年大流行性流感(H1N1)-2009 疫苗接种情况。
Vaccine. 2012 Jul 6;30(32):4744-51. doi: 10.1016/j.vaccine.2012.05.007. Epub 2012 May 18.
6
Influenza vaccination among healthcare personnel after pandemic influenza H1N1.大流行流感 H1N1 后医护人员的流感疫苗接种。
Vaccine. 2012 Jan 20;30(5):911-5. doi: 10.1016/j.vaccine.2011.11.095. Epub 2011 Dec 7.
7
Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.EudraVigilance 中甲型 H1N1 流感大流行疫苗的安全性监测。
Vaccine. 2011 Jun 10;29(26):4378-87. doi: 10.1016/j.vaccine.2011.04.005. Epub 2011 Apr 16.
8
Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.在 1 型糖尿病患者中,与 2009-2010 季节性流感疫苗联合使用时,含佐剂的 2009 年大流行流感 A(H1N1) MF59 疫苗具有持久的免疫原性和安全性。
Diabet Med. 2011 Dec;28(12):1530-6. doi: 10.1111/j.1464-5491.2011.03449.x.
9
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.在甲型 H1N1(2009)流感大流行期间,用 MF59(®)佐剂的细胞培养衍生疫苗 Celtura(®)进行的前瞻性观察性安全性研究。
Vaccine. 2012 Oct 5;30(45):6436-43. doi: 10.1016/j.vaccine.2012.08.005. Epub 2012 Aug 15.
10
[Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].[西班牙巴伦西亚自治区2009 - 2010年及2010 - 2011年大流行流感疫苗和季节性流感疫苗不良反应报告的差异]
Rev Esp Salud Publica. 2012 May-Jun;86(3):241-51. doi: 10.1590/S1135-57272012000300004.

引用本文的文献

1
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.疫苗的药物警戒:重要性、主要方面、前景与挑战——一篇叙述性综述
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
2
Evaluation of Reference Centers for Special Immunobiologicals implementation.特殊免疫生物制品参考中心实施情况评估。
Rev Saude Publica. 2016 Sep 1;50:58. doi: 10.1590/S1518-8787.2016050006183.
3
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance.患者参与及电子健康工具在药物警戒中的应用
Front Pharmacol. 2016 Apr 11;7:90. doi: 10.3389/fphar.2016.00090. eCollection 2016.